Bluefin Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-24,816	Closed	-$2.83M	–	366
2020 Q2	$2.83M	Buy	24,816 +15,044	+154%	+$1.72M	0.24%	46
2020 Q1	$751K	Sell	9,772 -94,789	-91%	-$7.28M	0.1%	93
2019 Q4	$13.5M	Buy	+104,561	New	+$13.5M	0.9%	22
2019 Q3	–	Hold	0	–	–	–	355